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ABSTRACT
Background: Hyperkinetic disorders such as hemichorea can be caused by cerebrovascular, infectious or inflammatory diseases or by 
metabolic conditions such as hyperglycaemia. Hyperglycaemic hemichorea is a rare movement disorder which is frequently misdiagnosed. 
It is characterized by involuntary, continuous, non-patterned movements on one side of the body, basal ganglia lesions seen on head CT or 
MRI, and clinical improvement after blood glucose normalization. We describe the case of a female patient with uncontrolled diabetes who 
presented with hemichorea. 
Case presentation: We report the case of a 69-year-old woman with type 2 diabetes who presented with abnormal movements of the right 
upper limb. She had no neurological signs other than hemichorea. Her blood glucose level was 349 mg/dl and her glycosylated haemoglobin 
level (HbA1c) was 10.5%. Head CT and MRI showed no changes in the basal ganglia or ischaemic lesions. The patient was started on insulin 
and haloperidol with clinical improvement.
Conclusion: Larger case series are needed to establish better understanding of the physiopathological mechanisms and diagnostic criteria of 
hyperglycaemic hemichorea. The most important diagnostic criterion is clinical improvement after glycaemic control. 
LEARNING POINTS
• Hyperglycaemia is a rare cause of hemichorea. 
• Better understanding of the physiopathology and the establishment of diagnostic criteria are required.
• Correction of the underlying hyperglycaemia will lead to rapid improvement of the movements and is the most important feature for 
diagnosis. 
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INTRODUCTION
Chorea is a hyperkinetic movement disorder caused by basal ganglia lesions[1]. Hyperglycaemic states are a rare cause and frequently 
misdiagnosed[1]. 
Hyperglycaemic hemichorea is characterized by clinical, imaging and treatment criteria. Patients present with involuntary random-
appearing, irregular, non-rhythmic lateralized movements on one side of the body, contralateral basal ganglia lesions on head CT scans or 
MRI, and clinical improvement after glycaemia normalization[2].
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It is also important to carry out a thorough differential diagnosis to rule out ischaemic cerebrovascular, inflammatory, infectious, 
neurodegenerative and other metabolic diseases[3]. 
We present the case of a 69-year-old woman with uncontrolled type 2 diabetes mellitus with chorea-like movements. Her symptoms 
resolved after glycaemic control was established. 
CASE DESCRIPTION
A 69-year-old woman presented with abnormal movements of the right upper limb which had begun 7 days previously. These movements 
were involuntary, rapid and irregular and did not spread to her torso, other limbs or face. No other conditions such as visual complaints, 
dizziness, limb weakness, facial deviation, slurred speech, squinting or double vision were present.
The patient had a previous history of hypertension, dyslipidaemia, type 2 diabetes and diabetic retinopathy. She was medicated with 
candesartan, hydrochlorothiazide, furosemide, simvastatin, metformin, sitagliptin and glimepiride. She did not smoke, drink alcohol or use 
illicit drugs. She did not have any family history of neurological disease. 
On examination she was conscious, her blood pressure was 126/61 mmHg, and she had no fever or cognitive impairment. She had no other 
neurological signs.
Her blood glucose level was 349 mg/dl (Table 1) and her glycosylated haemoglobin level (HbA1c) was 10.5% with no urinary ketones and 
with normal renal and liver function. A head CT scan showed an unspecific calcification in the right corona radiata and was negative for acute 
ischaemia, bleeding or mass in the vicinity of the basal ganglia. 
Table 1: Laboratory test
ALT - aspartate aminotransferase; AST - aspartate transaminase;
HbA1c -  glycosylated haemoglobin; CRP – C reactive protein; 
ESR – erythrocyte sedimentation rate; TSH – thyroid stimulating hormone
The patient was started on valproic acid and clonazepam with no clinical improvement.
She was admitted to our care for observation and treatment with levetiracetam.
An electroencephalogram did not show an epileptogenic pattern. A head MRI revealed no basal ganglia lesions, but did show T1 bilateral 
hyperdensities in subcortical regions and T2 hypodensity in white matter reported as a calcified lesion.
Values Normal range
Leucocytes 5.80×109/l 4.50–11.50
Neutrophils 63.9%
Platelet count 289×109/l 150–450×109/l
ESR 21 sec 0–20
Urea 47 mg/dl 16–42
Creatinine 0.8 mg/dl 0.5–1.2
Sodium 138 mEq/l 136–145
Potassium 4.3 mEq/l 3.4–4.4
Glucose 349 mg/dl 74–106
AST 31 IU/l 3–31
ALT 43 IU/l 3–31
CRP 0.24 mg/dl <0.50
HbA1c 10.5% 4.0–6.5
TSH 1.39 mIU/l 4.0–6.5
T4 1.0 ng/dl 0.9–1.8
Cholesterol 284 mg/dl ≤200
LDL 206 mg/dl <221
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Due to the suspicion of hyperglycaemic hemichorea, the patient was treated with NPH insulin (4 units in the morning, 6 units at lunch and 10 
units at dinner), glargine (22 units in the morning and 8 units at night) and haloperidol 1 mg in the morning and 2 mg at night. Blood glucose 
levels were maintained at 113–200 mg/dl during hospitalization and showed clinical improvement after 2 days of treatment. 
The patient was discharged 14 days later with mild choreiform movements and prescribed a pre-mixed insulin (75% NPH and 25% insulin 
lispro), 20 units in the morning and 10 units every night, and the same dose of haloperidol. After 2 weeks, at the first follow-up appointment, 
the patient denied new episodes of chorea, experiencing just the occasional tremor. Five months later, the patient had good insulin therapy 
adherence, was on a lower dose of haloperidol, and had a HbA1c of 6.5%. 
DISCUSSION
Hyperglycaemic chorea was described for the first time by Bedwell in 1960. He analysed 53 cases with mean of age 71 years who were 
predominantly Asian women, suggesting a genetic predisposition[4]. 
In 2017, the aetiology and pathophysiology of hyperglycaemic chorea are still unknown[3,5]. However, it is more frequently seen in patients 
with longstanding, poorly controlled type 2 diabetes mellitus but has also been reported in type 1 diabetes or as an initial presentation of 
diabetes[1]. 
Many mechanisms have been proposed for hyperglycaemic hemichorea. One theory suggests transient ischaemia caused by cerebrovascular 
insufficiency, petechial haemorrhage and hyperglycaemic hyperosmolarity with reduction in cerebral blood flow, which could explain the 
hyperintense signal on T1-weighted (T1W) images in MRI in basal ganglia[5]. It is also known that both gamma aminobutyric acid (GABA) 
and acetylcholine are alternative sources of energy in anaerobic pathways, as in hyperglycaemic states. The depletion of GABA causes 
metabolic acidosis and depression of Kreb’s cycle, while a reduction in acetate production causes depletion of acetylcholine[1,5], causing 
thalamus disinhibition and hyperkinesias[1]. Oestrogen-induced alterations in GABA and dopamine receptors in postmenopausal women 
can be observed, explaining the female predisposition[2]. 
Diagnosis is based on a triad of clinical, imaging and treatment criteria. Patients have unilateral, involuntary, random appearing movements. 
A head CT scan usually shows hyperdense unilateral or bilateral lesions of the basal ganglia, while the most common features seen on 
head MRI are hyperintense signals in the contralateral putamen on T1W images without surrounding oedema or mass effect[5]. Abnormal 
movements are reversible after blood glucose normalization[3], while slower improvement can be associated with typical or atypical 
antipsychotics, dopamine-depleting agents, benzodiazepines and anticonvulsants[5]. 
The differential diagnosis includes ischaemic/haemorrhagic stroke, encephalitis, vasculitis, systemic and central nervous system lupus, 
cerebral toxoplasmosis associated with AIDS, mass lesions, multiple sclerosis, Wilson’s disease, thyrotoxicosis and the side effects of drugs 
such as anticonvulsants, levodopa, oral contraceptives and neuroleptics[2, 3]. 
Prognosis is good, with remission of the symptoms in a few days, although abnormalities persisting for as long as 6 years have been reported[5]. 
CT and MRI abnormalities usually return to normal within weeks to months with or after the disappearance of abnormal movements[5].
We report a case of hyperglycaemic hemichorea in a woman with uncontrolled diabetes with retinopathy and HbA1c of 10.5%. The patient 
had some of the clinical and treatment criteria of the diagnostic triad but did not show changes in basal ganglia on head CT scan or MRI. This 
presentation has been reported before and could be explained by depletion of both GABA and acetylcholine[1,5]. 
CONCLUSION
Larger case series are needed to establish better understanding of the physiopathological mechanisms and diagnostic criteria for 
hyperglycaemic hemichorea. The diagnostic is difficult and a normal head CT or MRI does not rule out this condition. it is important to take 
a thorough history, rule out other causes of hemichorea and achieve clinical improvement with glycaemic control.
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